Search

Author/Creator Diels, J.

3. Clinical effectiveness and resource utilization of paliperidone ER for schizophrenia: Pharmacoepidemiologic International Longitudinal Antipsychotic Registry (PILAR). (July 2014)

Authors:
Schreiner, A.; Hargarter, L.; Hitschfield, K.; Lee, J.I.; Lenskaya, I.; Sulaiman, A.H.; Diels, J.; on behalf of the PILAR study group
Journal:
Current medical research and opinion
Issue:
Volume 30:Number 7(2014:Jul.)
Page Start:
1279
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. P898: COMPARISON OF TECLISTAMAB WITH BELANTAMAB MAFODOTIN IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA USING MATCHING-ADJUSTED INDIRECT TREATMENT COMPARISON. (23rd June 2022)

Authors:
Delforge, M.; Usmani, S. Z.; van de Donk, N. W.; Garfall, A. L.; Moreau, P.; Oriol, A.; Nooka, A. K.; Rosinol, L.; Bahlis, N.; Rodriguez-Otero, P.; Martin, T.; Diels, J.; Van Sanden, S.; Pei, L.; Ammann, E.; Kobos, R.; Slavcev, M.; Smit, J.; Londhe, A.; Krishnan, A.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
789
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. P904: CILTACABTAGENE AUTOLEUCEL VS TREATMENTS FROM REAL-WORLD CLINICAL PRACTICE FOR TRIPLE CLASS EXPOSED PATIENTS WITH MULTIPLE MYELOMA: ADJUSTED COMPARISONS BASED ON CARTITUDE-1 AND THE EMMY FRENCH COHORT. (23rd June 2022)

Authors:
Decaux, O.; Hulin, C.; Perrot, A.; Macro, M.; Frenzel, L.; Diels, J.; Perualila, N. J.; Ghilotti, F.; Haefliger, B.; Goldsztajn, E.; Vernet, S.; Thevenon, J.; Willaime, M.; Texier, N.; Schecter, J. M.; Madduri, D.; Jackson, C.; Valluri, S.; Moreau, P.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
795
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. P935: REAL WORLD COMPARATIVE ANALYSIS OF THE EFFICACY OF TECLISTAMAB VERSUS CURRENT TREATMENTS IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM THE LOCOMOTION STUDY. (23rd June 2022)

Authors:
Einsele, H.; Moreau, P.; Delforge, M.; van de Donk, N. W.; Ghilotti, F.; Diels, J.; Elsada, A.; Strulev, V.; Pei, L.; Kobos, R.; Smit, J.; Slavcev, M.; Weisel, K.; Mateos, M.-V.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
825
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. P971: ADJUSTED COMPARISON OF PATIENT REPORTED OUTCOMES FROM CARTITUDE-1 AND LOCOMMOTION COMPARING CILTACABTAGENE AUTOLEUCEL VERSUS REAL WORLD CLINICAL PRACTICE IN TRIPLE-CLASS EXPOSED MULTIPLE MYELOMA. (23rd June 2022)

Authors:
Weisel, K.; Mateos, M.-V.; Vincent, L.; Martin, T.; Berdeja, J. G.; Jakubowiak, A.; Jagannath, S.; Lin, Y.; Thilakarathne, P.; Ghilotti, F.; Diels, J.; Haefliger, B.; Hague, C.; Gonzalez, A.; Schecter, J. M.; Gries, K. S.; Strulev, V.; Nesheiwat, T.; Pacaud, L.; Einsele, H.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
861
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. PB2014: TECLISTAMAB VS SELINEXOR-DEXAMETHASONE IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA: A MATCHING-ADJUSTED INDIRECT COMPARISON. (23rd June 2022)

Authors:
Rosinol, L.; Usmani, S. Z.; Bahlis, N.; Krishnan, A. Y.; Nooka, A. K.; Oriol, A.; Delforge, M.; Garfall, A. L.; van de Donk, N. W.; Rodríguez Otero, P.; Martin, T. G.; Diels, J.; Van Sanden, S.; Pei, L.; Ammann, E.; Kobos, R.; Slavcev, M.; Smit, J.; Londhe, A.; Moreau, P.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1885
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗